4.7 Article

Neurological update: COVID-19

Journal

JOURNAL OF NEUROLOGY
Volume 268, Issue 11, Pages 4379-4387

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00415-021-10581-y

Keywords

COVID-19; Neuroimmunology; Cerebrovascular disease; Critical illness

Funding

  1. National Institute of Health Research

Ask authors/readers for more resources

COVID-19 is primarily a respiratory disease, but can also lead to neurological complications. The main processes causing neurological damage include cerebrovascular disease, immunologically mediated neurological disorders, and the harmful effects of critical illness on the nervous system. While it is still uncertain if the virus directly invades the nervous system, the large number of infections at present suggests that nervous system infection may not be a significant issue.
Coronavirus Disease 2019 is predominantly a disorder of the respiratory system, but neurological complications have been recognised since early in the pandemic. The major pathophysiological processes leading to neurological damage in COVID-19 are cerebrovascular disease, immunologically mediated neurological disorders and the detrimental effects of critical illness on the nervous system. It is still unclear whether direct invasion of the nervous system by the Severe Acute Respiratory Syndrome Coronavirus 2 occurs; given the vast numbers of people infected at this point, this uncertainty suggests that nervous system infection is unlikely to represent a significant issue if it occurs at all. In this review, we explore what has been learnt about the neurological complications of COVID-19 over the course of the pandemic, and by which mechanisms these complications most commonly occur.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Post-acute blood biomarkers and disease progression in traumatic brain injury

Virginia F. J. Newcombe, Nicholas J. Ashton, Jussi P. Posti, Ben Glocker, Anne Manktelow, Doris A. Chatfield, Stefan Winzeck, Edward Needham, Marta M. Correia, Guy B. Williams, Joel Simren, Riikka S. K. Takala, Ari J. Katila, Henna-Riikka Maanpaa, Jussi Tallus, Janek Frantzen, Kaj Blennow, Olli Tenovuo, Henrik Zetterberg, David K. Menon

Summary: Newcombe et al. found that serum levels of GFAP and neurofilament light remain elevated for months to years after traumatic brain injury and are correlated with microstructural injury and atrophy. These biomarkers may be able to identify survivors at risk of late neurological damage after traumatic brain injury.

BRAIN (2022)

Article Multidisciplinary Sciences

Cross-tissue immune cell analysis reveals tissue-specific features in humans

C. Dominguez Conde, C. Xu, L. B. Jarvis, D. B. Rainbow, S. B. Wells, T. Gomes, S. K. Howlett, O. Suchanek, K. Polanski, H. W. King, L. Mamanova, N. Huang, P. A. Szabo, L. Richardson, L. Bolt, E. S. Fasouli, K. T. Mahbubani, M. Prete, L. Tuck, N. Richoz, Z. K. Tuong, L. Campos, H. S. Mousa, E. J. Needham, S. Pritchard, T. Li, R. Elmentaite, J. Park, E. Rahmani, D. Chen, D. K. Menon, O. A. Bayraktar, L. K. James, K. B. Meyer, N. Yosef, M. R. Clatworthy, P. A. Sims, D. L. Farber, K. Saeb-Parsy, J. L. Jones, S. A. Teichmann

Summary: This study investigated immune cells in 16 human tissues using single-cell RNA sequencing and VDJ sequencing, revealing the distribution of finely phenotyped immune cell types across tissues and uncovering tissue-specific features and clonal architecture of T and B cells.

SCIENCE (2022)

Article Medicine, General & Internal

Health Care Resource Utilization in Management of Opioid-Naive Patients With Newly Diagnosed Neck Pain

Michael C. Jin, Michael Jensen, Zeyi Zhou, Adrian Rodrigues, Alexander Ren, Maria Isabel Barros Guinle, Anand Veeravagu, Corinna C. Zygourakis, Atman M. Desai, John K. Ratliff

Summary: This study examined the care patterns and healthcare utilization of patients with newly diagnosed neck pain. The results showed that early imaging without subsequent intervention was associated with significantly increased healthcare spending, while early conservative therapy was associated with lower costs and reduced long-term care inefficiency.

JAMA NETWORK OPEN (2022)

Article Clinical Neurology

Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses

Edward J. Needham, Alexander L. Ren, Richard J. Digby, Emma J. Norton, Soraya Ebrahimi, Joanne G. Outtrim, Doris A. Chatfield, Anne E. Manktelow, Maya M. Leibowitz, Virginia F. J. Newcombe, Rainer Doffinger, Gabriela Barcenas-Morales, Claudia Fonseca, Michael J. Taussig, Rowan M. Burnstein, Romit J. Samanta, Cordelia Dunai, Nyarie Sithole, Nicholas J. Ashton, Henrik Zetterberg, Magnus Gisslen, Arden Eden, Emelie Marklund, Peter J. M. Openshaw, Jake Dunning, Michael J. Griffiths, Jonathan Cavanagh, Gerome Breen, Sarosh R. Irani, Anne Elmer, Nathalie Kingston, Charlotte Summers, John R. Bradley, Leonie S. Taams, Benedict D. Michael, Edward T. Bullmore, Kenneth G. C. Smith, Paul A. Lyons, Alasdair J. Coles, David K. Menon

Summary: COVID-19 and influenza are both associated with brain injury, particularly in severe cases. The brain injury occurs in the context of dysregulated immune responses, with no single pathogenic mechanism clearly responsible. Blood biomarkers can be used to assess the extent and duration of brain injury.

BRAIN (2022)

Review Biochemistry & Molecular Biology

Neuro-Inflammation Modulation and Post-Traumatic Brain Injury Lesions: From Bench to Bed-Side

Alice Jacquens, Edward J. Needham, Elisa R. Zanier, Vincent Degos, Pierre Gressens, David Menon

Summary: Head trauma is a common cause of disability in young adults, and cranial trauma in children has particularities in terms of epidemiology, mechanism, and physiopathology. The long-term repercussions of head trauma can be attributed to chronic neuroinflammation, a complex process involving various actors. Numerous studies have explored different anti-inflammatory therapies for traumatic brain injury.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Clinical Neurology

Remyelination varies between and within lesions in multiple sclerosis following bexarotene

J. William L. Brown, Ferran Prados, Daniel R. Altmann, Baris Kanber, Jonathan Stutters, Nick G. Cunniffe, Joanne L. Jones, Zoya G. Georgieva, Edward J. Needham, Cyrus Daruwalla, Claudia Gandini Wheeler-Kingshott, Peter Connick, Siddharthan Chandran, Robin Franklin, David MacManus, Rebecca Samson, Alasdair Coles, Declan Chard

Summary: This study found that treatment response varies depending on the location and degree of abnormality in patients with multiple sclerosis. The remyelinating effect is more pronounced in gray matter lesions, and the post-processing of whole gray matter lesion measures is simpler and may reduce sample sizes.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2022)

Review Oncology

Immunometabolism, a new therapeutic development for immunotherapies of high-grade gliomas: a narrative review

Janet Y. Wu, Alexander L. Ren, Michael Lim

Summary: Immune cells in high-grade gliomas, like GBM, contribute to tumor growth and therapeutic resistance through various metabolic mechanisms, and metabolic optimization has been shown to improve certain immunotherapies. Therefore, immunometabolic research is crucial for future research and development of immunotherapy.

CHINESE CLINICAL ONCOLOGY (2022)

Review Clinical Neurology

Diagnosis of delirium: a practical approach

Sian K. Alexander, Edward Needham

Summary: Delirium is an acute disorder characterized by fluctuating attention and awareness, which can be distinguished from other causes of acute confusion. The cardinal features of delirium include fluctuations, prominent inattentiveness with cognitive deficits, changes in awareness, and visual hallucinations. Diagnosis of delirium relies on a thorough history and clinical examination, rather than any single test or combination of tests.

PRACTICAL NEUROLOGY (2023)

Article Clinical Neurology

Opioid Usage in Lumbar Disc Herniation Patients with Nonsurgical, Early Surgical, and Late Surgical Treatments

Zeyi Zhou, Michael C. Jin, Michael R. Jensen, Maria Isabel Barros Guinle, Alexander Ren, Ank A. Agarwal, Joshua Leaston, John K. Ratliff

Summary: This study aims to assess opioid usage in surgical and nonsurgical patients with lumbar disc herniation receiving different treatments and timing of treatments. The results showed that early surgery patients had lower average daily opioid usage, lower incidence of opioid use, and lower 1-year cumulative opioid usage burden compared to nonsurgical and late surgery patients.

WORLD NEUROSURGERY (2023)

Article Critical Care Medicine

Candidate Genetic and Molecular Drivers of Dysregulated Adaptive Immune Responses After Traumatic Brain Injury

Michal Duchniewicz, John Y. W. Lee, David K. Menon, Edward J. Needham

Summary: Neuroinflammation is a major factor in secondary injury after TBI, driven by immune responses in both the central and peripheral systems. Genetic factors play a significant role in TBI outcomes, particularly in adaptive immune responses. By analyzing GWAS datasets, specific genetic variants with high probability of effect can be identified despite limited sample sizes. The HLA class II locus has been highlighted as an important genetic factor in TBI, emphasizing the importance of genetic variance in adaptive immune responses.

JOURNAL OF NEUROTRAUMA (2023)

Article Computer Science, Information Systems

Selective prediction for extracting unstructured clinical data

Akshay Swaminathan, Ivan Lopez, William Wang, Ujwal Srivastava, Edward Tran, Aarohi Bhargava-Shah, Janet Y. Wu, Alexander L. Ren, Kaitlin Caoili, Brandon Bui, Layth Alkhani, Susan Lee, Nathan Mohit, Noel Seo, Nicholas Macedo, Winson Cheng, Charles Liu, Reena Thomas, Jonathan H. Chen, Olivier Gevaert

Summary: This study explores the role of selective prediction in improving the accuracy and efficiency of extracting unstructured clinical data. The results indicate that selective classifiers outperform non-selective classifiers and structured proxy variables to some extent. Selective prediction should be considered when abstaining is preferable to making an incorrect prediction.

JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2023)

Review Oncology

Translational Models in Glioma Immunotherapy Research

Alexander L. Ren, Janet Y. Wu, Si Yeon Lee, Michael Lim

Summary: Immunotherapy has potential for glioma treatment, but clinical trials have not shown significant improvements in patient survival. It is important for preclinical models in glioma research to accurately represent clinical features and immune mechanisms. This review explores common preclinical models in glioma immunology, discussing their advantages, disadvantages, and translational research applications.

CURRENT ONCOLOGY (2023)

Article Clinical Neurology

Ageing is associated with maladaptive immune response and worse outcome after traumatic brain injury

Federico Moro, Francesca Pischiutta, Anais Portet, Edward J. Needham, Emma J. Norton, John R. Ferdinand, Gloria Vegliante, Eliana Sammali, Rosaria Pascente, Enrico Caruso, Edoardo Micotti, Daniele Tolomeo, Rafael di Marco Barros, Erik Fraunberger, Kevin K. W. Wang, Michael J. Esser, David K. Menon, Menna R. Clatworthy, Elisa R. Zanier

Summary: Traumatic brain injury is increasingly common in older individuals and is associated with poor prognosis. Aging is associated with extra-cranial comorbidities and pre-existent pathologies, as well as a dysregulated and chronic inflammatory immune response. Studies on mice and clinical cohorts have shown that aged individuals have greater functional deficits and worse long-term outcomes after brain trauma, which are related to altered immune response in systemic, meningeal, and brain tissue.

BRAIN COMMUNICATIONS (2022)

No Data Available